Track GeneDx Holdings's accounts payable ($0) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
GeneDx Holdings (SMFR) currently reports a accounts payable of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore GeneDx Holdings's accounts payable history and peer comparisons.
GeneDx Holdings's accounts payable changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
GeneDx Holdings reported $0 in accounts payable as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GeneDx Holdings, and consider following SMFR for alerts when major investors trade the stock.
GeneDx Holdings is classified in the Healthcare sector. On accounts payable, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SMFR with unrelated industries.